355 results on '"Hartleb, Marek"'
Search Results
2. The prospective validation of a scoring system to assess mucosal cleanliness during EGD
3. Heterotopic Gastric Mucosa in the Proximal Esophagus: Prospective Study and Systematic Review on Relationships with Endoscopic Findings and Clinical Data
4. Impact of tumor size and location on endoscopic ultrasound-guided sampling of pancreatic neuroendocrine tumors: A recursive partitioning analysis
5. Influence of narrow-band imaging (NBI) and enhanced operator’s attention during esophagus inspection on cervical inlet patches detection
6. Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia
7. Correction to: Composite detection rate as an upper gastrointestinal endoscopy quality measure correlating with detection of neoplasia
8. Healthcare practitioners’ diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey
9. The survey of willingness to undergo screening gastroscopy in the population of low-to-moderate prevalence rate of esophageal and gastric cancers
10. The performance of biliary stents in malignant biliary strictures
11. Performance of biliary stents in malignant biliary strictures.
12. THE PROSPECTIVE VALIDATION OF CLEANLINESS IN THE UPPER DIGESTIVE TRACT ACCORDING TO POLPREP UPPER GASTROINTESTINAL CLEANLINESS SCALE IN REFERENCE TO ENDOSCOPIC FINDINGS - THE VISUAL STUDY
13. Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study
14. Liver phenotypes in PCOS : Analysis of exogenous and inherited risk factors for liver injury in two European cohorts
15. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability
16. Liver phenotypes in PCOS : Analysis of exogenous and inherited risk factors for liver injury in two European cohorts
17. Willingness to undergo screening gastroscopy in a population with low-to-moderate prevalence rate of esophageal and gastric cancer.
18. Potential benefits of one-time gastroscopy in searching for precancerous conditions
19. Fatty liver disease in PCOS: metabolic, genetic and hormonal phenotypes of two independent European cohorts
20. A MicroRNA-Based Test Improves Endoscopic Ultrasound–Guided Cytologic Diagnosis of Pancreatic Cancer
21. Procalcitonin and macrophage inflammatory protein-1 beta (MIP-1β) in serum and peritoneal fluid of patients with decompensated cirrhosis and spontaneous bacterial peritonitis
22. Non‐alcoholic fatty liver and advanced fibrosis in the elderly: Results from a community‐based Polish survey
23. Heterotopic Gastric Mucosa in the Proximal Esophagus: Prospective Study and Systematic Review on Relationships with Endoscopic Findings and Clinical Data
24. Wrzodziejące zapalenie jelita grubego - jak rozpoznawać i leczyć według aktualnych wytycznych?
25. The relation of esophagogastroduodenoscopy time and novel upper gastrointestinal quality measures
26. Quality of Life in Patients with Irritable Bowel Syndrome (IBS), Assessed Using the IBS–Quality of Life (IBS-QOL) Measure After 4 and 8 Weeks of Treatment with Mebeverine Hydrochloride or Pinaverium Bromide: Results of an International Prospective Observational Cohort Study in Poland, Egypt, Mexico and China
27. The role of endoscopic and demographic features in the diagnosis of gastric precancerous conditions
28. Critical flicker frequency fails to disclose brain dysfunction in patients with primary biliary cirrhosis
29. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
30. Performance of plastic stents used for benign and malignant biliary strictures; experience of single high-volume endoscopy unit
31. Scoring system assessing mucosal visibility of upper gastrointestinal tract: The POLPREP scale
32. Hepatic angiogenesis and fibrosis are common features in morbidly obese patients
33. Treatment of pruritus with Prometheus dialysis and absorption system in a patient with benign recurrent intrahepatic cholestasis
34. Analysis of Point Shear Wave Elastography and Biochemical Markers for the Detection of Liver Fibrosis
35. Guidelines for the management of patients with Crohn’s disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology
36. Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis
37. Healthcare practitioners' diagnostic and treatment practice patterns of nonalcoholic fatty liver disease in Poland: a cross-sectional survey.
38. A rare cause of chylous ascites
39. Influence of COVID-19 Pandemic on Endoscopic Procedures in Two European Large-Capacity Endoscopy Units: “Keep Calm, Keep Safe and Scope on?”
40. A Rare Mutation in The APOB Gene Associated with Neurological Manifestations in Familial Hypobetalipoproteinemia
41. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
42. Age and immunoglobulin G4-associated autoimmune hepatitis
43. Scoring system assessing mucosal visibility of upper gastrointestinal tract: The POLPREP scale.
44. Wytyczne postępowania diagnostyczno-terapeutycznego w raku wątrobowokomórkowym.
45. CYTOPHAGIC HEMORRHAGIC PANNICULITIS AND SEVERE STEATOHEPATITIS: CHALLENGING COMBINATION
46. Influence of COVID-19 Pandemic on Endoscopic Procedures in Two European Large-Capacity Endoscopy Units: "Keep Calm, Keep Safe and Scope on?".
47. HEPATIC ARTERIAL DOT SIGNS IN ISOLATED SMALL DUCT PRIMARY SCLEROSING CHOLANGITIS
48. Comparison of the Accuracy of Shear Wave Elastography and Acoustic Radiation Force Impulse in Determining Liver Fibrosis Among Patients With Chronic Liver Disease
49. Response of authors to the comment on ‘mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia’
50. Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.